NCT07490301 · Interventional trial
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
Overall registry status Recruiting
Phase 2 · Phase 3
Conditions Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Delaware Valley sites
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 280038 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory